GIANFILIPPI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 484
EU - Europa 276
AS - Asia 75
Continente sconosciuto - Info sul continente non disponibili 1
Totale 836
Nazione #
US - Stati Uniti d'America 482
CN - Cina 66
IE - Irlanda 59
FR - Francia 51
GB - Regno Unito 43
SE - Svezia 42
IT - Italia 33
DE - Germania 21
FI - Finlandia 13
BE - Belgio 5
VN - Vietnam 5
CA - Canada 2
ES - Italia 2
IR - Iran 2
PL - Polonia 2
RU - Federazione Russa 2
TR - Turchia 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
EU - Europa 1
Totale 836
Città #
Chandler 164
Ashburn 81
Dublin 59
Southend 40
Jacksonville 20
Wilmington 16
Lawrence 15
Princeton 15
Redmond 15
Beijing 13
Seattle 10
Helsinki 9
Sindelfingen 9
Ann Arbor 6
Brussels 5
Nanjing 5
Verona 5
Hebei 4
Jinan 4
New York 4
Fuzhou 3
Haikou 3
Levallois-perret 3
Norwalk 3
Shenyang 3
Taizhou 3
Bologna 2
Boydton 2
Cambridge 2
Changsha 2
Dong Ket 2
Dongguan 2
Fairfield 2
Frankfurt am Main 2
Jiaxing 2
Krakow 2
Madrid 2
Seregno 2
Tianjin 2
Trevenzuolo 2
Woodbridge 2
Berlin 1
Boardman 1
Brno 1
Cassano delle Murge 1
Edinburgh 1
Fremont 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Ho Chi Minh City 1
Laurel 1
Milan 1
Montignoso 1
Montréal 1
Negrar 1
Novokuznetsk 1
Palermo 1
San Francisco 1
San Mateo 1
Shenzhen 1
Tappahannock 1
Toronto 1
Washington 1
Zhengzhou 1
Totale 571
Nome #
accreditamento delle strutture odontoiatriche 85
Indagine sugli incidenti domestici nel territorio Veronese 70
Il percorso diagnostico-terapeutico ed assistenziale, tra sforzo organizzativo e benefici apprezzati: l’esperienza di un’Azienda ULSS del Veneto 67
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 63
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 57
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 54
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 52
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 51
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 49
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test 47
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 43
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 41
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 41
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 37
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 30
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 25
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 19
Impact of the COVID-19 pandemic on the volume of laboratory testing 13
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 12
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 10
Totale 866
Categoria #
all - tutte 3.250
article - articoli 2.669
book - libri 0
conference - conferenze 382
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 199
Totale 6.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 3 1 1 0
2019/202030 5 0 0 3 4 3 2 2 1 2 1 7
2020/202151 4 4 2 1 2 8 1 5 3 0 2 19
2021/2022162 30 29 7 11 10 1 1 7 13 6 18 29
2022/2023409 24 36 33 78 24 89 9 38 48 3 16 11
2023/2024181 10 11 15 20 29 22 19 54 1 0 0 0
Totale 866